These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12466224)

  • 1. Nitric oxide inhibits uptake of dopamine and N-methyl-4-phenylpyridinium (MPP+) but not release of MPP+ in rat C6 glioma cells expressing human dopamine transporter.
    Cao BJ; Reith ME
    Br J Pharmacol; 2002 Dec; 137(8):1155-62. PubMed ID: 12466224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
    Johnson RA; Eshleman AJ; Meyers T; Neve KA; Janowsky A
    Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine inhibits the release of MPP+ but not dopamine through the rat dopamine transporter.
    Kitayama S; Morita K; Dohi T
    Eur J Pharmacol; 1996 Aug; 309(1):107-9. PubMed ID: 8864700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide scavenger carboxy-PTIO potentiates the inhibition of dopamine uptake by nitric oxide donors.
    Cao BJ; Reith ME
    Eur J Pharmacol; 2002 Jul; 448(1):27-30. PubMed ID: 12126967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium.
    Pifl C; Giros B; Caron MG
    J Neurosci; 1993 Oct; 13(10):4246-53. PubMed ID: 8410185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species differences in functions of dopamine transporter: paucity of MPP+ uptake and cocaine binding in bovine dopamine transporter.
    Lee SH; Rhee J; Koh JK; Lee YS
    Neurosci Lett; 1996 Aug; 214(2-3):199-201. PubMed ID: 8878118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of the neuronal dopamine transporter activity in MPP(+)-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors.
    Barc S; Page G; Barrier L; Piriou A; Fauconneau B
    Neurosci Lett; 2001 Nov; 314(1-2):82-6. PubMed ID: 11698152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters.
    Scholze P; Sitte HH; Singer EA
    Neurosci Lett; 2001 Aug; 309(3):173-6. PubMed ID: 11514069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new in vitro approach for investigating the MPTP effect on DA uptake.
    Barc S; Page G; Fauconneau B; Barrier L; Huguet F
    Neurochem Int; 2001 Mar; 38(3):243-8. PubMed ID: 11099783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT).
    Bryan-Lluka LJ; Papacostas MH; Paczkowski FA; Wanstall JC
    Br J Pharmacol; 2004 Sep; 143(1):63-70. PubMed ID: 15302679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.
    Pifl C; Hornykiewicz O; Giros B; Caron MG
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1437-43. PubMed ID: 8667208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors.
    Kiss JP; Zsilla G; Vizi ES
    Neurochem Int; 2004 Sep; 45(4):485-9. PubMed ID: 15186914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium.
    Buck KJ; Amara SG
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12584-8. PubMed ID: 7809082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl-4-phenylpyridinium (MPP(+))-evoked dopamine release from rat striatal slices: possible roles of voltage-dependent calcium channels and reverse dopamine transport.
    Inazu M; Kubota N; Takeda H; Oguchi K; Koizumi M; Kimura S; Matsumiya T
    Neurochem Int; 2001 Sep; 39(3):253-60. PubMed ID: 11434982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
    Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Methyl-4-phenylpyridinium-induced down-regulation of dopamine transporter function correlates with a reduction in dopamine transporter cell surface expression.
    Chagkutip J; Vaughan RA; Govitrapong P; Ebadi M
    Biochem Biophys Res Commun; 2003 Nov; 311(1):49-54. PubMed ID: 14575693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of MPP(+) incorporation into cerebellar granule cells.
    González-Polo RA; Mora A; Clemente N; Sabio G; Centeno F; Soler G; Fuentes JM
    Brain Res Bull; 2001 Sep; 56(2):119-23. PubMed ID: 11704348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
    J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats.
    Banerjee R; Saravanan KS; Thomas B; Sindhu KM; Mohanakumar KP
    Neurochem Res; 2008 Jun; 33(6):985-95. PubMed ID: 17763941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.